A nationwide study has found that testing a developing fetus's DNA through chromosomal microarray (CMA) provides more information about potential disorders than does the standard method of prenatal testing, which is to visually examine the chromosomes (karyotyping). The study has the potential to change the standard method of prenatal testing.